Generate Biomedicines, Inc. Common Stock stock price
NASDAQ:GENB · NasdaqGenerate Biomedicines, Inc. Common Stock's chart data is dated 2026-11-16. There is no active technical signal. The display ticker is GENB.
- Generate Biomedicines, Inc. Common Stock's about 9 months (full record) range runs from $10.38 to $22.67. The latest close of $10.49 is near the bottom of that range (−53.7% from the high).
- By close, the price moved −13.2% over 1 month, −33.1% over 3 months, −19.4% over 6 months.
- No technical signal is active today.
Generate Biomedicines, Inc. Common Stock Talk · Newest
For account, order or payment questions, please send a 1:1 inquiry · 1:1 inquiry →
Loading Talk…
Generate Biomedicines, Inc. Common Stock last closed at $10.49 (-13.09%) on 2026-11-16. Listed on Nasdaq. The display ticker is GENB. The trading market is Nasdaq.
Generate Biomedicines, Inc. Common Stock overview
Generate Biomedicines, Inc. Common Stock is listed on Nasdaq. Only 182 trading days (about 9 months) are on record since 2026-02-27, so it is a recent listing.
About this company
Quantus's relationship data lists competitors: Amgen, Moderna, Regeneron Pharmaceuticals and 1 more; customers: GSK, Novartis, Sanofi and 3 more.
Related stocks
- AmgenCompetitor
- ModernaCompetitor
- Regeneron PharmaceuticalsCompetitor
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Generate Biomedicines, Inc. Common Stock, or open the plan table on the main site.
Ask Q about Generate Biomedicines, Inc. Common Stock.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.